The global Extracorporeal Membrane Oxygenation Machine Market was worth $531 million in 2021 and is predicted to rise at a steady CAGR of 5% from 2022 to 2032, reaching a valuation of US$ 908 million by the end of 2032.

Recent developments in extracorporeal membrane oxygenation systems market innovations such as miniaturization of ECMO components like hollow pumps, which are used in various surgeries, aids in the transportation of critically ill patients, thereby increasing the ECOM systems market size.

As per the ECOM systems market study, the rising use of ECMO has sparked technological advancements in extracorporeal membrane oxygenation machines of which oxygenators and heparin-coated cannulas are two major emerging trends in the ECOM systems market.

The study finds that extracorporeal membrane oxygenation devices are used in life-threatening situations when other forms of supportive care have failed. Furthermore, the use of ECMO in various healthcare settings has increased significantly owing to its wide range of applications.

The adoption of ECMO procedures is being promoted by several government organizations. One of them is GOLD (Global Initiative for Chronic Obstructive Lung Disease), a campaign that aims to raise awareness about COPD and its treatment, which includes the use of ECMO oxygen machine thereby positively influencing the ECMO systems adoption trends.

The sudden spike in COVID-19 cases, combined with an increase in the number of critically ill patients requiring additional life support, has pushed up demand for ECMO machines. For patients with severe acute respiratory distress syndrome, extracorporeal membrane oxygenation therapy has been the preferred treatment option.

An increasing number of supportive government policies and the rapid FDA approval of extracorporeal membrane oxygenation equipment for emergency use have significantly increased the ECOM systems market opportunities.

Competitive Landscape: Companies like Medtronic plc (U.S.), Fresenius Medical care A.G. & Co. KGAA (Germany), Getinge Group (Sweden), Microport (China), Origin Biomedical (U.S.), Terumo Cardiovascular Systems Corporation, Livanova plc (U.K.), Nipro Corporation (Japan), Euro sets S.R.L. (Italy), Cytosorbents Corporation (Australia), and Abiomed. dominate the global market.

Browse More@

Key Segments 

By Product:

  • ECMO Machines
    • Portable Devices
    • Static Devices
  • Software

By Service Type:

  • Application
  • Middleware
  • Infrastructure

By Component:

  • Pumps
  • Oxygenators
  • Controllers
  • Cannul
  • Assessories

By Modality:

  • Veno-Venous
  • Veno-Arterials
  • Arterio-Venous

By Patient Type:

  • Neonates
  • Pediatrics
  • Adults